Healthcare -
Biotechnology - NASDAQ - US
$ 0.52
-2.62 %
$ 20.1 M
Market Cap
-0.18
P/E
ATHA - OPERATING EXPENSES
Operating Expenses ATHA - Athira Pharma, Inc.
125 M
LAST VALUE
50.78%
2 YEAR CAGR
90.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR